NeoGenomics (NASDAQ:NEO) Announces Results, Beats Estimates By $0.01 EPS

   2019-10-31 19:10

NeoGenomics (NASDAQ:NEO) posted its quarterly earnings results on Tuesday. The medical research company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.01, Bloomberg Earnings reports. NeoGenomics had a return on equity of 4.60% and a net margin of 0.55%. The business had revenue of $104.70 million during the quarter, compared to analysts’ expectations of $99.38 million. During the same quarter last year, the company posted $0.05 earnings per share. NeoGen…




Original Source